Skip to content

Quick ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.8×-0.3×
Stryker logo
StrykerSYK
1.3×+0.3×
CONMED logo
CONMEDCNMD
0.0×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.9×-0.5×
Enovis logo
EnovisENOV
0.9×-0.2×
OrthoPediatrics logo
OrthoPediatricsKIDS
2.4×-0.6×

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-22.3%
Enterprise value$320.25M-19.0%
P/S1.3×-0.3×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s quick ratio?
Treace Medical Concepts, Inc. (TMCI) reported quick ratio of 2.5× in Q1 2026.
How has Treace Medical Concepts, Inc.'s quick ratio changed year-over-year?
Treace Medical Concepts, Inc.'s quick ratio decreased by 24.8% year-over-year, from 3.4× to 2.5×.
What is the long-term trend for Treace Medical Concepts, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Treace Medical Concepts, Inc.'s quick ratio has grown at a 1.9% compound annual growth rate (CAGR), from 2.9× to 3.1×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.